SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-018204
Filing Date
2022-11-25
Accepted
2022-11-25 16:05:26
Documents
13
Period of Report
2022-11-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K eqrx-20221123x8k.htm   iXBRL 8-K 46505
  Complete submission text file 0001558370-22-018204.txt   207393

Data Files

Seq Description Document Type Size
2 EX-101.SCH eqrx-20221123.xsd EX-101.SCH 4292
3 EX-101.DEF eqrx-20221123_def.xml EX-101.DEF 14397
4 EX-101.LAB eqrx-20221123_lab.xml EX-101.LAB 21091
5 EX-101.PRE eqrx-20221123_pre.xml EX-101.PRE 15605
7 EXTRACTED XBRL INSTANCE DOCUMENT eqrx-20221123x8k_htm.xml XML 7363
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 6173152266
EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 221420196
SIC: 2834 Pharmaceutical Preparations